- Antiangiogenesis therapy: an update after the first decade
-
De Falco S
- KMID: 1792005
- Korean J Intern Med.
- 2014 Jan;29(1):1-11.
- doi: 10.3904/kjim.2014.29.1.1
Angiogenesis is a complex biological phenomenon that forms new blood vessels from the pre-existing vasculature. Aberrant angiogenesis has been implicated in a variety of diseases such as cancer, atherosclerosis, arthritis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Hypoxia in Hepatocellular Carcinoma
-
Myung SJ, Yoon JH
- KMID: 760700
- Korean J Hepatol.
- 2007 Mar;13(1):9-19.
Hepatocellular carcinoma (HCC) is characterized by hypervascularity, indicating that angiogenesis plays a vital role in HCC growth and progression. A number of anti-angiogenic therapies are being utilized in clinical trials... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Serous Retinal Detachment Associated with Choroidal Ischemia with Intravitreal Bevacizumab Following Brain Surgery
-
Cho YJ, Choi EY, Koh HJ, Lee SC, Kim M
- KMID: 2344268
- Korean J Ophthalmol.
- 2014 Oct;28(5):424-426.
- doi: 10.3341/kjo.2014.28.5.424
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor or Steroid Injection in Diabetic Macular Edema According to Fluid Turbidity in Optical Coherence Tomography
-
Lee K, Chung H, Park Y, Sohn J
- KMID: 2344221
- Korean J Ophthalmol.
- 2014 Aug;28(4):298-305.
PURPOSE: To determine if short term effects of intravitreal anti-vascular endothelial growth factor or steroid injection are correlated with fluid turbidity, as detected by spectral domain optical coherence tomography (SD-OCT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
-
Park SU, Lee SJ, Kim M
- KMID: 2344222
- Korean J Ophthalmol.
- 2014 Aug;28(4):306-313.
PURPOSE: To evaluate the efficacy of anti-vascular endothelial growth factor (VEGF) compared with observation for treating acute central serous chorioretinopathy (CSC). METHODS: A retrospective study of 36 patients with acute CSC,... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
-
Chang YS, Han JI, Yoo SJ, Lew YJ, Kim JH
- KMID: 2345823
- Korean J Ophthalmol.
- 2014 Dec;28(6):466-472.
- doi: 10.3341/kjo.2014.28.6.466
PURPOSE: To investigate 12-month treatment outcomes of anti-vascular endothelial growth factor therapy in eyes with typical exudative age-related macular degeneration with good baseline visual acuity. METHODS: This retrospective observational case series... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
-
Kim JH, Lee DW, Choi SC, Kim JW, Lee TG, Kim CG, Cho HJ
- KMID: 2363848
- Korean J Ophthalmol.
- 2015 Dec;29(6):404-410.
- doi: 10.3341/kjo.2015.29.6.404
PURPOSE: To evaluate the 12-month outcome of anti-vascular endothelial growth factor (VEGF) treatment for extrafoveal polypoidal choroidal vasculopathy (PCV). METHODS: This retrospective observational study included 32 eyes of 32 patients newly... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
-
Kim JH, Seo HW, Han HC, Lee JH, Choi SK, Lee D
- KMID: 1705418
- Korean J Ophthalmol.
- 2013 Aug;27(4):235-242.
- doi: 10.3341/kjo.2013.27.4.235
PURPOSE: To compare the short term effects of bevacizumab and ranibizumab injections on the regression of corneal neovascularization (NV). METHODS: Sixteen eyes of 16 patients with corneal NV were randomly assigned... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration
-
Lee KH, Chin HS, Kim NR, Moon YS
- KMID: 2363847
- Korean J Ophthalmol.
- 2015 Dec;29(6):396-403.
- doi: 10.3341/kjo.2015.29.6.396
PURPOSE: To investigate the effects of vitreomacular traction (VMT) on ranibizumab treatment response for neovascular age-related macular degeneration (AMD). METHODS: A retrospective review of 85 eyes of 85 patients newly diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Findings of Visual Outcome in Spectral Domain Optical Coherence Tomography after Ranibizumab Treatment in Age-related Macular Degeneration
-
Kwon YH, Lee DK, Kim HE, Kwon OW
- KMID: 2344262
- Korean J Ophthalmol.
- 2014 Oct;28(5):386-392.
- doi: 10.3341/kjo.2014.28.5.386
PURPOSE: To investigate which spectral domain optical coherence tomography (SD-OCT) findings predict visual outcome after anti-vascular endothelial growth factor (VEGF) treatment in neovascular age-related macular degeneration (NV-AMD). METHODS: We reviewed the... -
- CITED
-
- Close
- SHARE
-
- Close
- Resolution of Severe Macular Edema in Adult Coats' Disease with Intravitreal Triamcinolone and Bevacizumab Injection
-
Jun JH, Kim YC, Kim KS
- KMID: 1070757
- Korean J Ophthalmol.
- 2008 Sep;22(3):190-193.
- doi: 10.3341/kjo.2008.22.3.190
A 47 year old male patient visited our hospital with the chief complaint of deterioration of the visual acuity in the left eye. The fundus examination revealed thick hard exudates,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection
-
Kim MW, Moon H, Yang SJ, Joe SG
- KMID: 2363887
- Korean J Ophthalmol.
- 2016 Feb;30(1):25-31.
- doi: 10.3341/kjo.2016.30.1.25
PURPOSE: To evaluate the effects of posterior subtenon triamcinolone acetonide injection on refractory diabetic macular edema (DME) after intravitreal bevacizumab (IVB) injection failure. METHODS: Patients with DME and central subfield thickness... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration
-
Lee JY, Chung H, Kim HC
- KMID: 2363886
- Korean J Ophthalmol.
- 2016 Feb;30(1):17-24.
- doi: 10.3341/kjo.2016.30.1.17
PURPOSE: To describe the changes of fundus autofluorescence (FAF) in patients with age-related macular degeneration before and after intravitreal injection of anti-vascular endothelial growth factor according to the type of... -
- CITED
-
- Close
- SHARE
-
- Close
- Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
-
Martin JY, Urban RR, Liao JB, Goff BA
- KMID: 2374249
- J Gynecol Oncol.
- 2016 Sep;27(5):e47.
- doi: 10.3802/jgo.2016.27.e47
OBJECTIVE: Bevacizumab was recently approved by the US Food and Drug Administration for use in recurrent platinum resistant epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Idiopathic Central Serous Chorioretinopathy in a 12-year-old Male Treated with Bevacizumab
-
Kim YC, Kim SD, Kim KS
- KMID: 1397492
- Korean J Ophthalmol.
- 2012 Oct;26(5):391-393.
- doi: 10.3341/kjo.2012.26.5.391
A 12-year-old male presented with a chief complaint of a 1-month-history of decreased visual acuity in his right eye. The patient had no past history of steroid use or other... -
- CITED
-
- Close
- SHARE
-
- Close
- A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma
-
Chang HJ, Lee JH, Do YR, Bae SH, Lee JL, Nam SH, Yoon SS, Bang SM
- KMID: 1729242
- Korean J Intern Med.
- 2011 Dec;26(4):403-409.
- doi: 10.3904/kjim.2011.26.4.403
BACKGROUND/AIMS: The clinical efficacy and safety of a three-drug combination of melphalan, prednisone, and thalidomide were assessed in patients with multiple myeloma who were not candidates for high-dose therapy as... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
-
Chung EJ, Kang SJ, Koo JS, Choi YJ, Grossniklaus HE, Koh HJ
- KMID: 1106450
- Yonsei Med J.
- 2011 Jan;52(1):151-157.
- doi: 10.3349/ymj.2011.52.1.151
PURPOSE: To investigate the effect of bevacizumab (Avastin; Genentech, San Francisco, CA, USA) on vascular endothelial growth factor (VEGF) expression and inflammation in fibrovascular membranes in patients with proliferative diabetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response?
-
Kim YN, Lee HY, Lee KS, Seo JB, Chung MJ, Ahn MJ, Park K, Kim TS, Yi CA
- KMID: 1397500
- Korean J Radiol.
- 2012 Dec;13(6):702-710.
- doi: 10.3348/kjr.2012.13.6.702
OBJECTIVE: To evaluate tumor responses in patients treated with anti-angiogenic agents for non-small cell lung cancer (NSCLC) by assessing intratumoral changes using a dual-energy CT (DECT) (based on Choi's criteria)... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria
-
Lee HY, Lee KS, Hwang HS, Lee JW, Ahn MJ, Park K, Kim TS, Yi CA, Chung MJ
- KMID: 1119224
- Korean J Radiol.
- 2010 Dec;11(6):618-626.
- doi: 10.3348/kjr.2010.11.6.618
OBJECTIVE: We wanted to compare the efficacy of the new CT response evaluation criteria for predicting the tumor progression-free survival (PFS) with that of RECIST 1.1 in non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
